REQUEST A DEMO
Total
USD $0.00
Search more companies

Olimax Nt Sp. z o.o. (Poland)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Olimax Nt Sp. z o.o. Profile Updated: March 02, 2022
Buy our report for this company USD 29.95 Most recent financial data: 2021 Available in: English & Polish Download a sample report

Olimax Nt Sp. z o.o. is an enterprise based in Poland. Its main office is in Bilcza. The company operates in the Pharmaceutical Preparation Manufacturing industry. The company was established on January 10, 2006. 11 - 50 (2024) employees currently work for Olimax Nt Sp. z o.o.. There was a net sales revenue increase of 111.18% reported in Olimax Nt Sp. z o.o.’s latest financial highlights for 2021. There was a total negative growth of 18.11% in Olimax Nt Sp. z o.o.’s total assets over the same period. In, 2021, the company’s net profit margin increased by 379.98%.

Headquarters
Ul. Bukowa 2
Bilcza; Swietokrzyskie; Postal Code: 26-026

Contact Details: Purchase the Olimax Nt Sp. z o.o. report to view the information.

Website: http://www.olimax.pl

Basic Information
Total Employees:
Purchase the Olimax Nt Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Olimax Nt Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Olimax Nt Sp. z o.o. report to view the information.
Incorporation Date:
January 10, 2006
Key Executives
Subsidiaries
Instytut Technologii Zaawansowanych Sp. z o.o.
50%
Company Performance
Financial values in the chart are available after Olimax Nt Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
111.18%
Total operating revenue
3.39%
Operating profit (EBIT)
18.29%
EBITDA
42.32%
Net Profit (Loss) for the Period
69.17%
Total assets
-18.11%
Total equity
-17.59%
Operating Profit Margin (ROS)
217.6%
Net Profit Margin
379.98%
Return on Equity (ROE)
-42.51%
Debt to Equity Ratio
0.43%
Quick Ratio
-0.98%
Cash Ratio
-0.99%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?